The uranium bipyridyl metallocene, [η-1,3-(MeSi)CH]U(bipy) (), is readily accessible in good yield by adding potassium graphite (KC) to a mixture of [η-1,3-(MeSi)CH]UCl () and 2,2'-bipyridine. Compound was fully characterized and employed for small-molecule activation. It has been demonstrated that may serve as a synthon for [η-1,3-(MeSi)CH]U(II) fragment in the presence of PhE (E = S, Se), alkynes, and a variety of hetero-unsaturated molecules such as diazabutadienes, azine (PhC═N), -benzoquinone, pyridine -oxide, CS, isothiocyanates, and organic azides. However, upon exposure of to thio-ketone PhCS, aldehyde -MePhCHO, ketone PhCO, imine PhCH═NPh, azine (PhCH═N), and nitrile PhCN, it may also promote C-C coupling reactions forming [η-1,3-(MeSi)CH]U[(bipy)(PhCS)] (), [η-1,3-(MeSi)CH]U[(bipy)(-MePhCHO)] (), [η-1,3-(MeSi)CH]U[(bipy)(PhCO)] (), [η-1,3-(MeSi)CH]U[(bipy)(PhCHNPh)] (), [η-1,3-(MeSi)CH]U[(bipy)(PhCHNN═CHPh)] (), and [η-1,3-(MeSi)CH]U[(NCHC(Ph)NH)] (), respectively, in quantitative conversion. Furthermore, in the presence of CuI, a single-electron transfer (SET) process is observed to yield the uranium(III) iodide complex [η-1,3-(MeSi)CH]U(I)(bipy) ().
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.inorgchem.2c00423 | DOI Listing |
Anticancer Agents Med Chem
January 2025
Cancer Center, The Second Hospital of Shandong University, Jinan, Shandong, 250033, China.
Dysregulated lipid metabolism within the tumor microenvironment (TME) is a critical hallmark of cancer progression, with lipids serving as a major energy source for tumor cells. Beyond their role in cell membrane synthesis, lipids also provide essential substrates for biomolecule production and activate signaling pathways that regulate various cellular processes. Aberrant lipid metabolism impacts not only function but also alters the behavior of immune and stromal cells within the TME.
View Article and Find Full Text PDFCommun Biol
January 2025
Translational Inflammation Research, Medical Faculty, Otto von Guericke University (OvGU), Magdeburg, Magdeburg, Germany.
Extrinsic apoptotic network is driven by Death Ligand (DL)-mediated activation of procaspase-8. Recently, we have developed the first-in class small molecule, FLIPinB, which specifically targets the key regulator of extrinsic apoptosis, the protein c-FLIP, in the caspase-8/c-FLIP heterodimer. We have shown that FLIPinB enhances DL-induced caspase-8 activity and apoptosis.
View Article and Find Full Text PDFCell Death Differ
January 2025
Department of Hepatobiliary Surgery of the affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China.
Lysine lactylation plays critical roles in various diseases, including cancer. Our previous study showed that lactylation of non-histone ABCF1 may be involved in hepatocellular carcinoma (HCC) progression. In this study, we evaluated the prognostic value of ABCF1-K430la in HCC using immunohistochemical staining and performed amino acid point mutations, multi-omics crossover, and biochemical experiments to investigate its biological role and underlying mechanism.
View Article and Find Full Text PDFInt Immunopharmacol
January 2025
Department of Geriatric Medicine, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong Province, China. Electronic address:
Cytokine storm is a life-threatening systemic hyper-inflammatory state caused by different etiologies, in which the bulk production of pro-inflammatory cytokines from activated macrophages has a central role. Integrated stress response (ISR) comprises several protective signaling pathways, leading to phosphorylation of eukaryotic initiation factor 2α (eIF2α) and repression of protein translation. Emerging evidence suggests that ISR induction may elicit anti-inflammatory effects.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Indiana University, Indianapolis, IN, USA.
Background: Preclinical testing in animal models is a critical component of the drug discovery process. Over the past three decades hundreds of interventions have demonstrated preclinical efficacy for ameliorating cognitive impairments in animal models; however, none have translated to efficacy in Alzheimer's disease (AD) clinical trials. This lack of translation suggests that there are issues with the animal models employed, the preclinical assays, and poor scientific rigor and reproducibility during execution.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!